Cerenome Expects $1.55 Million in CNSide® Third Quarter Gross Billings
Cerenome reports $1.55 million in preliminary Q3 CNSide gross billings, advances payer coverage and plans an expanded test menu in Q4.
Cerenome reports $1.55 million in preliminary Q3 CNSide gross billings, advances payer coverage and plans an expanded test menu in Q4.